glp 1 gip 1 The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology GIP (Gastric Inhibitory Polypeptide) Assay

Br J Nutr (2014) 111:84753

It is the leading cause of irreversible blindness globally, with projections indicating it could affect over 100 million individuals by 2040 (74)

10.1016/j.brainres.2013.07.018 Brain Res

The global digestive enzyme supplement market was estimated at $699.4 million in 2021 and is projected to grow to $1.64 billion by 2031.2 Digestive enzyme supplements are designed to improve the digestion and absorption of certain food components

Kinetic analysis of the metabotropic glutamate subtype 5 tracer [(18)F]FPEB in bolus and bolus-plus-constant-infusion studies in humans

The indole-3-acetamide-induced arabidopsis transcription factor MYB74 decreases plant growth and contributes to the control of osmotic stress responses